We are live on
!
Find out more
6CM
683 Capital Management Portfolio holdings
AUM
$1.92B
1-Year Est. Return
85.52%
This Fund
S&P 500
This Quarter
Est. Return
+17.29%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.22B
AUM Growth
-$65.3M
(-5.1%)
Cap. Flow
-$208M
Cap. Flow
% of AUM
-16.99%
Top 10 Holdings %
Top 10 Hldgs %
34.8%
Holding
287
New
134
Increased
23
Reduced
46
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BorgWarner
BWA
|
+$20.6M |
| 2 |
Hilton Grand Vacations
HGV
|
+$19M |
| 3 |
Carvana
CVNA
|
+$12.5M |
| 4 |
NCR Atleos
NATL
|
+$9.39M |
| 5 |
Sarepta Therapeutics
SRPT
|
+$6.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enova International
ENVA
|
+$28.6M |
| 2 |
FLG
Flagstar Bank National Association
FLG
|
+$24.5M |
| 3 |
Vistra
VST
|
+$18.3M |
| 4 |
Noble Corp
NE
|
+$16.1M |
| 5 |
Phinia Inc
PHIN
|
+$8.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Consumer Discretionary | 18.74% |
| 3 | Financials | 10.52% |
| 4 | Materials | 4.8% |
| 5 | Industrials | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYPH
76
Cypherpunk Technologies Inc
CYPH
$78.2M
| $1.87M | 0.15% |
450,000
-40,000
| -8% | -$86.6K |
|
77
Modular Medical
MODD
$11M
| $1.71M | 0.14% |
31,299
| – | – |
|
78
Ardelyx
ARDX
$1.2B
| $1.69M | 0.14% |
+272,000
| New | +$1.22M |
|
79
CALL
Harmony Biosciences
HRMY
$2.2B
| $1.61M | 0.13% |
+50,000
| New | +$1.4M |
|
80
Karooooo
KARO
$2.06B
| $1.59M | 0.13% |
65,591
+1,591
| +2% | +$38.2K |
|
81
Fennec Pharmaceuticals
FENC
$366M
| $1.57M | 0.13% |
140,000
-160,000
| -53% | -$1.33M |
|
|
FLG
82
Flagstar Bank National Association
FLG
$5.99B
| $1.53M | 0.13% |
50,000
-816,667
| -94% | -$24.5M |
|
|
IRS.WS
83
DELISTED
IRSA Inversiones y Representaciones S.A. Warrants
IRS.WS
| $1.51M | 0.12% |
3,081,812
+1,453,551
| +89% | +$683K |
|
84
CALL
Moderna
MRNA
$22.4B
| $1.49M | 0.12% |
15,000
-15,000
| -50% | -$1.26M |
|
|
GCTS
85
GCT Semiconductor Holding
GCTS
$208M
| $1.42M | 0.12% |
134,938
| – | – |
|
86
InflaRx
IFRX
$261M
| $1.42M | 0.12% |
870,000
-1,480,000
| -63% | -$2.54M |
|
|
IMTXW
87
DELISTED
Immatics N.V. Warrants
IMTXW
| $1.23M | 0.1% |
420,000
| – | – |
|
|
CRESW
88
DELISTED
Cresud SACIF y A. Warrant
CRESW
| $1.19M | 0.1% |
2,043,560
+98,242
| +5% | +$45.5K |
|
89
Ponce Financial Group
PDLB
$495M
| $1.04M | 0.08% |
106,137
| – | – |
|
90
IN8bio
INAB
$9.37M
| $848K | 0.07% |
+20,492
| New | +$655K |
|
|
KYNB
91
Kyntra Bio
KYNB
$28.1M
| $621K | 0.05% |
+28,010
| New | +$423K |
|
|
EIGR
92
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $471K | 0.04% |
70,000
-18,333
| -21% | -$161K |
|
|
WHWK
93
Whitehawk Therapeutics
WHWK
$202M
| $404K | 0.03% |
+200,000
| New | +$839K |
|
|
ESPR
94
DELISTED
Esperion Therapeutics
ESPR
| $403K | 0.03% |
+134,689
| New | +$175K |
|
|
SLRN
95
DELISTED
ACELYRIN
SLRN
| $400K | 0.03% |
+53,630
| New | +$458K |
|
96
The Honest Company
HNST
$430M
| $391K | 0.03% |
+118,494
| New | +$216K |
|
|
ML
97
DELISTED
MoneyLion Inc.
ML
| $367K | 0.03% |
+5,860
| New | +$197K |
|
98
Porch Group
PRCH
$1.79B
| $367K | 0.03% |
+119,034
| New | +$167K |
|
|
LYRA
99
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $366K | 0.03% |
+1,397
| New | +$253K |
|
|
PLL
100
DELISTED
Piedmont Lithium
PLL
| $353K | 0.03% |
+12,500
| New | +$367K |
|
Similar funds
QOP
RIL
MC
RCAG
BOH
DCM
CC
IAN
683 Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, 683 Capital Management held 287 positions worth $1.22B, down 5.1% from $1.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
683 Capital Management withdrew a net $208M in Q4 2023, closing 28 positions and reducing 46 holdings. Its most notable exit was Hess, an estimated $7.65M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, 683 Capital Management opened a new position in NCR Atleos worth $9.96M.
- 683 Capital Management's largest Q4 2023 buy was NCR Atleos: 410,000 shares worth $9.96M.
- 683 Capital Management added most to BorgWarner in Q4 2023, an estimated $20.6M increase.
- 683 Capital Management's biggest Q4 2023 reduction was Enova International, cutting an estimated $28.6M.
- 683 Capital Management fully exited Hess in Q4 2023, selling an estimated $7.65M.
- 683 Capital Management's ten largest holdings make up 35% of its $1.22B portfolio in Q4 2023.
- 683 Capital Management opened 134 new positions and closed 28 in Q4 2023.
- 683 Capital Management's portfolio value fell 5.1% quarter-over-quarter to $1.22B.
Based on 683 Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.